Quantcast
Last updated on April 20, 2014 at 13:20 EDT

Latest Steroids Stories

2014-04-02 08:33:03

Researchers Continue to Reveal Benefits to Consuming Anthocyanin-Rich Foods like Strawberries WATSONVILLE, Calif., April 2, 2014 /PRNewswire-USNewswire/ -- According to new published research in the Journal of Nutrition, consumption of anthocyanin-rich foods such as strawberries may play an important role in lowering cholesterol and other risk factors for cardiovascular disease. To evaluate the effects of strawberries on cardiovascular risk factors, researchers at Oklahoma State University...

2014-04-01 08:28:50

New investigational PCSK9 inhibitor shown to significantly reduce LDL-C among Japanese patients BRIDGEWATER, N.J. and TARRYTOWN, N.Y., April 1, 2014 /PRNewswire/ -- Sanofi (EURONEXT: SAN and NYSE: SNY) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the first Phase 2 study with alirocumab, an investigational monoclonal antibody targeting PCSK9 (proprotein convertase subtilisin/kexin type 9), in Japanese patients met its primary endpoint. The results...

2014-03-28 08:26:53

U.S. Healthcare Professionals Now Can Perform Lab-Accurate Lipid and Liver Diagnostics with a simple fingerstick using the Piccolo® Blood Chemistry Analyzer. UNION CITY, Calif., March 28, 2014 /PRNewswire/ -- Abaxis, Inc. (NasdaqGS: ABAX), a medical products company manufacturing point-of-care blood analysis systems, today announced the Food and Drug Administration granted CLIA waived status for capillary draw for CHOL, HDL and TRIG. Combined with existing CLIA waived tests for...

2014-03-24 20:23:34

Five Phase 3 Studies With Evolocumab (AMG 145) to be Featured in Late-Breaking and Clinical Research Presentations - Data Form the Basis of Global Filing Plan THOUSAND OAKS, Calif., March 24, 2014 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that it will present pivotal Phase 3 data from five clinical studies evaluating evolocumab (AMG 145), an investigational fully human monoclonal antibody that inhibits PCSK9, a protein that reduces the liver's ability to remove low-density...

2014-03-17 08:30:17

Study Meets Primary Endpoint of LDL Cholesterol Reduction THOUSAND OAKS, Calif., March 17, 2014 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the Phase 3 TESLA (Trial Evaluating PCSK9 Antibody in Subjects with LDL Receptor Abnormalities) trial evaluating evolocumab met its primary endpoint of the percent reduction from baseline at week 12 in low-density lipoprotein cholesterol (LDL-C). The percent reduction in LDL-C, or "bad" cholesterol, was clinically meaningful and statistically...

2014-03-07 16:22:46

ALEXANDRIA, Va., March 7, 2014 /PRNewswire/ -- A new study just released in the American Journal of Clinical Nutrition found that different flavors of peanuts - salted, spicy, honey-roasted, or unsalted - result in positive health benefits. The study, "A Randomized Trial on the Effects of Flavorings on the Health Benefits of Daily Peanut Consumption," was conducted at Purdue University and included over 150 men and women who incorporated peanuts into their daily diet for 12 weeks....

2014-03-03 23:01:45

Kyowa Hakko USA announces that Pantesin is a comprehensive and safe dietary supplement that supports healthy cholesterol levels. New York, NY (PRWEB) March 03, 2014 A recently published study in Vascular Health and Risk Management showed that Pantesin® Pantethine was effective in lowering cardiovascular risk markers in study participants with low to moderate risk factors who were eligible for statin therapy. Specifically when compared to placebo, Pantesin showed significant changes...

Adding More Fish To Your Diet Can Increase Good Cholesterol
2014-03-03 12:49:29

Lee Rannals for redOrbit.com - Your Universe Online Adding more fish to your diet could help boost good cholesterol levels, according to a new study published in PLOS ONE. Scientists at the University of Eastern Finland found that people who increase their intake of fish to a minimum of three to four fatty fish servings per week could increase the number of HDL particles in their blood, which are believed to protect against cardiovascular diseases. Although many studies have been...

2014-02-26 23:32:28

Fatty Liver Bible & Ezra Protocol designed by Debra E is the latest program that teaches people how to lose weight and get the body they desired. A full Fatty Liver Bible & Ezra Protocol review on the site HealthReviewCenter.com indicates if this program is worth buying. Seattle, Wa (PRWEB) February 26, 2014 Fatty Liver Bible & Ezra Protocol is a new solution for fatty liver sufferers who want to take control of their health. The program also teaches them how to deal with...

Cholesterol-Lowering Benefits Of The Strawberry
2014-02-26 07:15:44

[ Watch the Video: The Health Benefits Of Strawberries ] FECYT - Spanish Foundation for Science and Technology A team of volunteers ate half a kilo of strawberries a day for a month to see whether it altered their blood parameters in any way. At the end of this unusual treatment, their levels of bad cholesterol and triglycerides reduced significantly, according to the analyses conducted by Italian and Spanish scientists. Several studies had already demonstrated the antioxidant...